1. Home
  2. LIDR vs ATYR Comparison

LIDR vs ATYR Comparison

Compare LIDR & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AEye Inc.

LIDR

AEye Inc.

HOLD

Current Price

$1.83

Market Cap

69.8M

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.85

Market Cap

73.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIDR
ATYR
Founded
2013
2005
Country
United States
United States
Employees
45
58
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.8M
73.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LIDR
ATYR
Price
$1.83
$0.85
Analyst Decision
Strong Buy
Hold
Analyst Count
1
9
Target Price
$6.00
$3.67
AVG Volume (30 Days)
4.4M
1.0M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2,510.73
N/A
Revenue Next Year
$486.88
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.64
52 Week High
$6.44
$7.29

Technical Indicators

Market Signals
Indicator
LIDR
ATYR
Relative Strength Index (RSI) 49.46 50.25
Support Level $1.80 $0.67
Resistance Level $2.65 $0.85
Average True Range (ATR) 0.27 0.05
MACD -0.02 0.00
Stochastic Oscillator 25.00 66.86

Price Performance

Historical Comparison
LIDR
ATYR

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: